Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 7, 2025

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.2K

Cellular Radiosensitivity of Soft Tissue Sarcoma.

R L Haas1, B G J Floot2, A N Scholten1

  • 1Department of Radiotherapy, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

Radiation Research
|April 29, 2021
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental infection of wild <i>Mastomys natalensis</i> with the parasitic nematode <i>Trichuris mastomysi</i>.

Journal of helminthology·2026
Same author

Independent patient access to imaging digital health records: Oncology patients' and healthcare professionals' views and preferences.

Radiography (London, England : 1995)·2026
Same author

Major wound complications after conventional preoperative radiotherapy in STS patients: incidence, predictors, and timing.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Doubting T(h)OMAS: has the era of precision oncology arrived in uterine leiomyosarcoma?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

medRxiv : the preprint server for health sciences·2026
Same author

Health-related quality of life in patients with gastrointestinal stromal tumor: data from a real-world cohort compared with a normative population.

ESMO real world data and digital oncology·2026
Same journal

KRT6A Impairs Radiosensitivity in Cervical Squamous Cell Carcinoma by Enhancing Fatty Acid Synthesis.

Radiation research·2026
Same journal

Chromosomal Instability: A Potential Biomarker of Radiation Response.

Radiation research·2026
Same journal

Antioxidant Probucol Reduces Mortality in Mice Exposed to Lethal Doses of Ionizing Radiation.

Radiation research·2026
Same journal

The Detection of Radiation Effects in the Urine of Rhesus Macaques Using Raman Spectroscopy.

Radiation research·2026
Same journal

Characterization of Radiation-responsive Genes and Transcript Variants under Different Radiation Qualities, Doses and Dose Rates.

Radiation research·2026
Same journal

Methyl Quercetin Inhibits Radiation-induced Senescence and TGF-β1-induced Myofibroblast Differentiation Through Psmad3/TGF-Β Signaling.

Radiation research·2026
See all related articles
This summary is machine-generated.

This study reveals significant differences in how various soft tissue sarcoma (STS) subtypes respond to radiation. Synovial sarcomas are more radiosensitive than myxoid liposarcomas and leiomyosarcomas, suggesting tailored radiotherapy approaches.

Area of Science:

  • Radiation Oncology
  • Cancer Biology
  • Sarcoma Research

Background:

  • Current soft tissue sarcoma (STS) radiotherapy regimens are standardized, overlooking potential subtype-specific radiosensitivities.
  • Understanding cellular radiosensitivity is crucial for optimizing radiation therapy in diverse STS subtypes.

Purpose of the Study:

  • To investigate and compare the cellular radiosensitivity across a panel of STS cell lines.
  • To identify potential subtype-specific differences in radiation response within STS.

Main Methods:

  • Clonogenic survival assays were performed on fourteen STS cell lines from synovial sarcoma, leiomyosarcoma, fibrosarcoma, and liposarcoma origins.
  • Cells were irradiated with single doses (1-8 Gy), and surviving fraction (SF) was calculated.
  • Alpha/beta (α/β) ratios were determined using the linear-quadratic (LQ) model.

More Related Videos

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.0K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.7K

Related Experiment Videos

Last Updated: Nov 7, 2025

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.2K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.0K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.7K

Main Results:

  • Significant heterogeneity in cellular radiosensitivity was observed across STS cell lines (SF2 ranged from 0.27 to 0.76).
  • Synovial sarcomas exhibited significantly higher radiosensitivity (mean SF2 = 0.35) compared to myxoid liposarcomas and leiomyosarcomas.
  • Myxoid liposarcoma cell lines demonstrated a relatively homogeneous and radioresistant phenotype.

Conclusions:

  • STS cell lines display a wide spectrum of radiosensitivities, with notable subtype-specific variations.
  • Synovial sarcoma cells are particularly radiosensitive, supporting the need for individualized radiotherapy strategies in clinical settings.